Jameie Melika, Bordbar Sanaz, Samiee Reza, Amanollahi Mobina, Azizmohammad Looha Mehdi, Aleyasin Mir Sajjad, Abdol Homayuni Mohammad Reza, Mozafar Mehrdad, Jameie Seyed Behnamedin, Akhondzadeh Shahin
Neuroscience Research Center, Iran University of Medical Sciences, Tehran, Iran.
Iranian Center of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
PLoS One. 2025 Mar 28;20(3):e0319171. doi: 10.1371/journal.pone.0319171. eCollection 2025.
The role of toll-like receptor 4 (TLR4) in schizophrenia remains unclear, with studies reporting conflicting results on its expression and activation in persons with schizophrenia (PwSCZ). This systematic review/meta-analysis compared basal monocytic TLR4 expression, as well as its activation pattern between PwSCZ and healthy controls (HCs).
This study was registered with PROSPERO (CRD42021273858) and adhered to the PRISMA guidelines. A systematic search was conducted through MEDLINE (via PubMed), Web of Science, and Scopus from inception to December 12, 2023. Quantitative syntheses were conducted for (a) basal monocytic TLR4 density, (b) basal percentage of TLR4+ monocytes, and (c) basal TLR4 gene expression. Effect sizes were computed using Hedges' g for mean differences. Random-effect models with restricted maximum-likelihood estimation were used, and subgrouping was conducted based on antipsychotic status. The studies' risk of bias was assessed using the Joanna Briggs Institute (JBI) tool.
Eleven studies (473 PwSCZ, 416 HCs) were included. Pooled analysis revealed a nonsignificant trend toward increased basal monocytic TLR4 density in PwSCZ (Hedges' g = 0.317 [95% CI: -0.060, 0.694], τ2 = 0.127, I2 = 68.91%). The difference became significant after sensitivity analysis and excluding one study (Hedges' g = 0.469 [0.195,0.742], p = 0.001). No significant difference was found between the groups in terms of TLR4+ monocytes percentage (Hedges' g = 0.235 [-0.245, 0.715], τ2 = 0.31, I2 = 87.30%) or TLR4 gene expression (Hedges' g = 0.179 [-0.502, 0.861], τ2 = 0.29, I2 = 79.04%). According to qualitative synthesis, TLR4 stimulation resulted in reduced monocytic activation in PwSCZ compared to HCs.
This study suggested a trend toward an increased basal monocytic TLR4 density in PwSCZ, with no difference in the basal percentage of TLR4+ monocytes or TLR4 gene expression. However, the limited available data underscores the need for future studies.
Toll样受体4(TLR4)在精神分裂症中的作用尚不清楚,关于其在精神分裂症患者(PwSCZ)中的表达和激活情况,研究报告的结果相互矛盾。本系统评价/荟萃分析比较了PwSCZ与健康对照(HCs)之间基础单核细胞TLR4表达及其激活模式。
本研究已在PROSPERO(CRD42021273858)注册,并遵循PRISMA指南。从数据库建立至2023年12月12日,通过MEDLINE(经由PubMed)、科学网和Scopus进行了系统检索。对以下方面进行了定量综合分析:(a)基础单核细胞TLR4密度,(b)TLR4+单核细胞的基础百分比,以及(c)基础TLR4基因表达。使用Hedges' g计算效应量以评估均值差异。采用限制最大似然估计的随机效应模型,并根据抗精神病药物使用情况进行亚组分析。使用乔安娜·布里格斯研究所(JBI)工具评估研究的偏倚风险。
纳入了11项研究(473例PwSCZ,416例HCs)。汇总分析显示,PwSCZ的基础单核细胞TLR4密度有增加的趋势,但差异无统计学意义(Hedges' g = 0.317 [95% CI:-0.060,0.694],τ2 = 0.127,I2 = 68.91%)。敏感性分析并排除一项研究后,差异变得显著(Hedges' g = 0.469 [0.195,0.742],p = 0.001)。两组在TLR4+单核细胞百分比(Hedges' g = 0.235 [-0.245,0.715],τ2 = 0.31,I2 = 87.30%)或TLR4基因表达(Hedges' g = 0.179 [-0.502,0.861],τ2 = 0.29,I2 = 79.04%)方面未发现显著差异。根据定性综合分析,与HCs相比,TLR4刺激导致PwSCZ的单核细胞激活减少。
本研究表明PwSCZ的基础单核细胞TLR4密度有增加趋势,TLR4+单核细胞的基础百分比或TLR4基因表达无差异。然而,现有数据有限,强调了未来研究的必要性。